A pharmacovigilance study of the association between tetracyclines and hepatotoxicity based on Food and Drug Administration adverse event reporting system data

被引:33
作者
Wei, Chunyan [1 ,2 ]
Liu, Ying [1 ]
Jiang, Aidou [1 ]
Wu, Bin [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Pharm, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Coll Pharm, Chengdu 610041, Sichuan, Peoples R China
关键词
Doxycycline; Drug-induced liver injury; Minocycline; Pharmacovigilance; Tigecycline; INDUCED LIVER-INJURY; SAFETY; TIGECYCLINE; MINOCYCLINE; ACNE; POPULATION; DOXYCYCLINE; INFECTIONS; EFFICACY; OUTCOMES;
D O I
10.1007/s11096-022-01397-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background While tetracycline antibiotics are commonly prescribed in practice, the risk of drug-induced liver injury (DILI) remains controversial. Aim To evaluate the association of DILI with tetracycline antibiotics. Method All DILI cases of tetracycline antibiotics as primary suspected drugs were extracted from the US Food and Drug Administration adverse event reporting system (FAERS). The outcomes included severe DILI, hepatocellular injury, cholestatic injury, and liver failure. Disproportionality analyses were conducted by estimating the reporting odds ratio (ROR) and the information component (IC). Results A total of 1,435 liver injury cases associated with tetracycline antibiotics were identified. The DILI signal was detected in tigecycline, minocycline, and doxycycline. The RORs and the 95% confidence intervals (95% CI) of tigecycline, minocycline, and doxycycline were (ROR 5.85, 95% CI 4.96-6.91), (ROR 6.4, 95% CI 5.76-7.11), and (ROR 2.07, 95% CI 1.86-2.31), respectively. Compared to minocycline (ROR 5.5, 95% CI 4.94-6.12; IC 2.35, 95% CI 1.98-2.68) and doxycycline (ROR 1.91, 95% CI 1.71-2.12; IC 0.91, 95% CI 0.55-1.26), tigecycline showed a stronger association with hepatocellular injury (ROR 7.11, 95% CI 6.13-8.23; IC 2.68, 95% CI 2.16-3.13). Tigecycline also showed a stronger association with cholestatic injury (ROR 12.16, 95% CI 10.13-14.61; IC 3.51, 95% CI 2.79-4) than minocycline (ROR 3.23, 95% CI 2.59-4.04; IC 1.67, 95% CI 0.9-2.37) or doxycycline (ROR 2.86, 95% CI 2.47-3.31; IC 1.5, 95% CI 1-1.97). Tigecycline (ROR 6.56, 95% CI 4.57-9.41; IC 2.69, 95% CI 1.28-3.64) and minocycline (ROR 4.22, 95% CI 3.14-5.66; IC 2.06, 95% CI 1-2.93) showed a significant association with liver failure. Conclusion The data mining of FAERS suggested an association between DILI and tigecycline, minocycline, and doxycycline.
引用
收藏
页码:709 / 716
页数:8
相关论文
共 48 条
  • [1] HEPATIC TOXICITY OF TETRACYCLINE IN PREGNANCY
    ALLEN, ES
    BROWN, WE
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1966, 95 (01) : 12 - &
  • [2] A Bayesian neural network method for adverse drug reaction signal generation
    Bate, A
    Lindquist, M
    Edwards, IR
    Olsson, S
    Orre, R
    Lansner, A
    De Freitas, RM
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (04) : 315 - 321
  • [3] Bettesda MD, 2019, LIVER TOX CLIN RES I
  • [4] Oral Antibacterial Therapy for Acne Vulgaris: An Evidence-Based Review
    Bienenfeld, Amanda
    Nagler, Arielle R.
    Orlow, Seth J.
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2017, 18 (04) : 469 - 490
  • [5] Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden
    Björnsson, E
    Jerlstad, P
    Bergqvist, A
    Olsson, R
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2005, 40 (09) : 1095 - 1101
  • [6] Hepatotoxicity by Drugs: The Most Common Implicated Agents
    Bjornsson, Einar S.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (02)
  • [7] Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland
    Bjornsson, Einar S.
    Bergmann, Ottar M.
    Bjornsson, Helgi K.
    Kvaran, Runar B.
    Olafsson, Sigurdur
    [J]. GASTROENTEROLOGY, 2013, 144 (07) : 1419 - U168
  • [8] Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock
    Borsuk-De Moor, Agnieszka
    Rypulak, Elzbieta
    Potrec, Beata
    Piwowarczyk, Pawel
    Borys, Michal
    Sysiak, Justyna
    Onichimowski, Dariusz
    Raszewski, Grzegorz
    Czuczwar, Miroslaw
    Wiczling, Pawel
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
  • [9] Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
    Chalasani, Naga
    Bonkovsky, Herbert L.
    Fontana, Robert
    Lee, William
    Stolz, Andrew
    Talwalkar, Jayant
    Reddy, K. Rajendar
    Watkins, Paul B.
    Navarro, Victor
    Barnhart, Huiman
    Gu, Jiezhun
    [J]. GASTROENTEROLOGY, 2015, 148 (07) : 1340 - +
  • [10] Drug-induced Cholestasis: Mechanisms, Models, and Markers
    Chatterjee, Sagnik
    Annaert, Pieter
    [J]. CURRENT DRUG METABOLISM, 2018, 19 (10) : 808 - 818